跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
INVOKAMET - Health Canada Drug Approval Details
Approvals
/
Health Canada
/
INVOKAMET
Authorized
STANDARD
INVOKAMET
Janssen Inc
🇨🇦 Health Canada
Approval Date
Jul 4, 2025
Approval ID
1f1cb44af6b20821
Company
Janssen Inc
Type
Standard
Approval Details
Approval Id
1f1cb44af6b20821
Drug Approval Canada Name
INVOKAMET
Product Name
INVOKAMET
Status
Marketed
Status Date
2016-06-28
Original Market Date
2016-06-28
Din
02455455
Drug Class
Human
Dosage Form
Tablet
Route Of Administration
Oral
Schedule
Prescription
Ahfs
68:20.04
Atc Original
A10BD16 METFORMIN AND CANAGLIFLOZIN
Atc Name
a 10 bd 16
Aig Number
0258190006
Company Name
Janssen Inc
Company Address
19 Green Belt Drive, Toronto, Ontario, Canada, M3C 1L9
Company Detail Path
/organization/janssen-inc
Company Information
Pharmaceutical Company Name
Janssen Inc.
Name En
Janssen Inc.
Country Name
Canada
Province Name
Ontario
City Name
north york,ontario,country_ca
Address
19 Green Belt Dr
Active Ingredients
CANAGLIFLOZIN
150 MG
METFORMIN HYDROCHLORIDE
1000 MG
Authorized
Quick Info
Agency
Health Canada
Country
🇨🇦
Approval Date
Jul 4, 2025
Approval ID
1f1cb44af6b20821
Type
Standard
Back to Health Canada Approvals